Cells rely on tiny molecules called microRNAs to tune which genes are active and when. Cells must carefully control the lifespan of microRNAs to prevent widespread disruption to gene regulation. A new ...

HONG KONG SAR, China and SHENZHEN, China and CAMBRIDGE, Mass., March 17, 2026 /PRNewswire/ -- Innorna, a clinical‑stage biotech company advancing RNA medicines, today announced that the U.S. Food and ...

Researchers are redesigning lipid nanoparticles to do more than shuttle mRNA into cells, with preclinical studies suggesting ...

A metabolic enzyme also binds and unwinds RNA to promote translation of cell cycle genes. This dual role links energy status ...

Researchers developed DoriVac, a DNA origami-based vaccine platform that precisely arranges antigens and adjuvants to enhance ...

For patients living with Systemic Lupus Erythematosus (SLE), their immune systems mistakenly attack themselves, unleashing dangerous and painful levels of inflammation. For many, the goal is to reach ...

Treatments that target a fragment of the mutant protein that causes Huntington's disease might be more effective than ...

HHS plans 200M cancer vaccine initiative to fund public-private partnerships studying vaccines for high-risk cancer patients.

Treatments that target a fragment of the mutant protein that causes Huntington's disease might be more effective than treatments, now in clinical ...

EnTRUST accelerator grants support commercialization by Puerto Rico teams. #NewsismyBusiness - Stay updated with the latest Puerto Rico business news, economy insights, finance, retail, tourism, and ...

Chronic neuropathic pain in mice is maintained by the translation of messenger RNA in inhibitory neurons, so drugs that modulate translational pathways may be able to treat this condition.

Engineers at the University of Pennsylvania have developed a new type of lipid nanoparticle (LNP) that could one day serve as a universal immunotherapy for cancers that form solid tumors, including ...